News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Taiwan Semi, Goldman and GE Aerospace are big earnings due with the market improving. Nvidia, Sandisk, Micron, Robinhood are near buy points.
US equity indexes traded mixed this week as growth sectors lifted the Nasdaq Composite and S&P 500 a
(Updates with index/price moves and geopolitical news from the first paragraph.) US equity indexe
Sometimes, little-known stocks are worth buying.
(Updates with latest market prices and developments.) US benchmark equity indexes were higher int
Picture a 62-year-old sitting across from his financial advisor in 2010. The finance pro pulls up the standard chart: wait until 70, get the biggest possible check, protect against longevity risk. The client listens, then files for Social Security anyway. Sixteen years later, at 78, his portfolio sits at roughly $900,000 and he is convinced ... He Claimed Social Security at 62 Against His Advisor’s Advice. At 78, His $900,000 Portfolio Says It Was the Right Call.
A weak stock market wouldn’t be the only painful outcome of a Mag Seven collapse. It could also risk tipping the economy into recession.
SPRU faces weather-driven revenue pressure, refinancing risks and a slowing residential market, but recurring cash flows, AI-led efficiencies and acquisition opportunities support long-term potential.
Insperity currently trades at $44.35 per share and has shown little upside over the past six months, posting a small loss of 2%. The stock also fell short of the S&P 500’s 7.2% gain during that period.
Carter's has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 10.3% to $39.30 per share while the index has gained 7.2%.
The stock hit an all-time high Thursday as investors look for hedges against massive artificial-intelligence investments elsewhere in the market.
Woodward currently trades at $403.73 and has been a dream stock for shareholders. It’s returned 230% since July 2021, more than tripling the S&P 500’s 70.5% gain. The company has also beaten the index over the past six months as its stock price is up 23.8% thanks to its solid quarterly results.
Halozyme Therapeutics trades at $78.57 and has moved in lockstep with the market. Its shares have returned 8.5% over the last six months while the S&P 500 has gained 7.2%.
Over the past six months, Polaris’s stock price fell to $65.60. Shareholders have lost 7.1% of their capital, which is disappointing considering the S&P 500 has climbed by 7.2%. This might have investors contemplating their next move.
Since January 2026, Perma-Fix has been in a holding pattern, posting a small loss of 3% while floating around $14.24. The stock also fell short of the S&P 500’s 7.2% gain during that period.
Dell stock got a bump when President Trump touted its products. But strong fundamentals are among more important factors as it eyes an entry.
Ciena's optical networking systems became essential AI infrastructure in 2026. But the rally came with a hefty dose of valuation risk.
The FTSE 100 closed at 10,497.29, up some 24.84 points.
Over the last six months, Dine Brands’s shares have sunk to $35.04, producing a disappointing 6% loss - a stark contrast to the S&P 500’s 7.2% gain. This may have investors wondering how to approach the situation.
(Updates with index/price moves and company/geopolitical news from the first paragraph.) US equit
Over the past six months, Albertsons’s shares (currently trading at $14.30) have posted a disappointing 17% loss, well below the S&P 500’s 7.2% gain. This may have investors wondering how to approach the situation.
Hayward has been treading water for the past six months, recording a small loss of 1.8% while holding steady at $16.06. The stock also fell short of the S&P 500’s 7.2% gain during that period.
SK Hynix made its U.S. trading debut with its American depositary receipts listing on the Nasdaq. The Korean memory chip maker ADR opened 14% above its offer price. The three major indexes were narrowly mixed.
The Iran war and a tug-of-war between AI stocks and other parts of the market have left the S&P 500 stuck in a range. On Friday, the S&P 500’s healthcare sector was the only major sector trading down more than 0.1%: It was down 0.7%. Moderna was the S&P’s biggest laggard, while UnitedHealth was the big drag on the Dow.
Over the last six months, Coupang’s shares have sunk to $19.11, producing a disappointing 13.8% loss - a stark contrast to the S&P 500’s 7.2% gain. This might have investors contemplating their next move.